Literature DB >> 11328660

Interactions of PC/Chol and PS/Chol liposomes with human cells in vitro.

E Papadimitriou1, S G Antimisiaris.   

Abstract

Interactions between phosphatidylcholine (PC) or phosphatidylserine (PS) liposomes and human umbilical vein endothelial cells (HUVEC) or human promyelocytic leukemia cells (HL60) were investigated. Pyramine encapsulating or rhodamine incorporating small unilamellar liposomes with mean diameters around 80 nm (demonstrated to retain encapsulated material and to be nontoxic under experimental conditions) were used. Liposome uptake by both types of cells increased when increasing amounts of vesicles were co-incubated. For both lipid compositions, the interaction with HUVEC was very fast (association reached a plateau within 5 min) and so was the release of internalized vesicles (90% within 10 min at 37 degrees C). The reduced association values at 4 degrees C and the punctuate fluorescence observed in the cell cytoplasm after interaction, were indicative of whole liposome internalization. This internalization was clathrin-independent, since it was not inhibited by sodium azide and deoxyglucose. Pre-treatment of HUVEC with filipin or NEM resulted in modification of the interaction, something that could be due to alterations in the biochemical characteristics of HUVEC membranes that inhibit vesicular processes. In HL-60 cells, a slower association and faster release of PC/Chol liposomes was demonstrated, while association of both liposomes with these cells was energy-and temperature-independent. Nevertheless, morphological studies revealed differences in the interactions: A bright fluorescent rim observed after interaction with PC/Chol liposomes, suggests that these liposomes were adsorbed on the surface of HL60 cells, while the uniform cytoplasmic fluorescence observed after incubation with PS/Chol liposomes was indicative of fusion as the interaction mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11328660     DOI: 10.3109/10611860008997910

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  4 in total

1.  Arsonoliposomes, a novel class of arsenic-containing liposomes: effect of palmitoyl-arsonolipid-containing liposomes on the viability of cancer and normal cells in culture.

Authors:  Olga Gortzi; Evangelia Papadimitriou; Christos G Kontoyannis; Sophia G Antimisiaris; Panayiotis V Ioannou
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

Review 2.  Angiogenesis in eye disease: immunity gained or immunity lost?

Authors:  Thomas A Ferguson; Rajendra S Apte
Journal:  Semin Immunopathol       Date:  2008-02-23       Impact factor: 9.623

3.  Macrophages inhibit neovascularization in a murine model of age-related macular degeneration.

Authors:  Rajendra S Apte; Jennifer Richter; John Herndon; Thomas A Ferguson
Journal:  PLoS Med       Date:  2006-08       Impact factor: 11.069

4.  Efficacy of immunoliposomes on cancer models in a cell-surface-antigen-density-dependent manner.

Authors:  S Hosokawa; T Tagawa; H Niki; Y Hirakawa; K Nohga; K Nagaike
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.